Exane Derivatives’s MaxCyte MXCT Stock Holding History

Exane Derivatives’s Portfolio MXCT Stock Details MXCT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.33K	Buy
2022 Q1	–	Sell
2021 Q4	$278K	Sell
2021 Q3	$411K	Buy